UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
Form 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: 3/31/03
-----------------------
Check Here if Amendment / /; Amendment Number:
---------
This Amendment (Check only one.): / / is a restatement.
/ / adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Hambrecht & Quist Capital Management LLC
-----------------------------------------
Address: 30 Rowes Wharf
-----------------------------------------
Boston, MA 02110
-----------------------------------------
-----------------------------------------
Form 13F File Number: 28-04219
---------------------
The institutional investment manager filing this report and the person by
whom it is signed hereby represent that the person signing the report is
authorized to submit it, that all information contained herein is true,
correct and complete, and that it is understood that all required items,
statements, schedules, lists, and tables, are considered integral parts of
this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Kim Carroll
-------------------------------
Title: Treasurer
-------------------------------
Phone: 617-772-8525
-------------------------------
Signature, Place, and Date of Signing:
Kim Carroll Boston, MA 05/09/03
------------------------------- ----------------- -------------
[Signature] [City, State] [Date]
Report Type (Check only one.):
/X/ 13F HOLDINGS REPORT. (Check here if all holdings of this reporting
manager are reported in this report.)
/ / 13F NOTICE. (Check here if no holdings reported are in this report,
and all holdings are reported by other reporting manager(s).)
/ / 13F COMBINATION REPORT. (Check here if a portion of the holdings for
this reporting manager are reported in this report and a portion are
reported by other reporting manager(s).)
Report Type (Check only one.):
/X/ 13F HOLDINGS REPORT. (Check here if all holdings of this reporting
manager are reported in this report.)
/ / 13F NOTICE. (Check here if no holdings reported are in this report,
Form 13F SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 0
------------
Form 13F Information Table Entry Total: 41
------------
Form 13F Information Table Value Total: $204,773,797
------------
(thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
[If there are no entries in this list, state "NONE" and omit the column headings
and list entries.]
No. Form 13F File Number Name
--- -------------------- -------------------
as of 3/31/03 FORM 13F
Name of Reporting Manager: HAMBRECHT & QUIST CAPITAL MANAGEMENT LLC (SEC USE ONLY)
Page 1 of 2
ITEM 6: ITEM 8:
ITEM 5: INVESTMENT DISCRETION VOTING
ITEM 1: ITEM 2: ITEM 3: ITEM 4: SHARES OF --------------------- ITEM 7: AUTHORITY (SHARES)
NAME OF ISSUER TITLE OF CUSIP FAIR MARKET PRINCIPAL (b) SHARED- (c) MANAGERS --------------------
CLASS NUMBER VALUE AMOUNT (a) AS DEFINED SHARED- SEE (a) (b) (c)
SOLE IN INSTR. V OTHER INSTR. V SOLE SHARED NONE
-----------------------------------------------------------------------------------------------------------------------------------
Abgenix Common 00039B107 $4,306,500 495,000 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Adolor Common 00724X102 5,134,371 518,100 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Aradigm Common 038505103 437,500 350,000 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Biofield Common 090591207 237,294 878,866 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Biofield (Restricted) Common 090591207 216,000 1,000,000 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Biopure Common 09065H915 566,951 169,746 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
BioTransplant Common 09066Y107 106,878 712,518 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Catalytica Energy
Systems Common 148884109 327,714 128,515 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Celgene Common 151020104 17,995,200 690,000 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Charles River Labs Common 159864107 3,626,392 142,100 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Corixa Common 21887F100 4,901,524 716,597 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Cubist
Pharmaceuticals Common 229990981 7,673,620 958,005 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
CV Therapeutics Common 126667104 9,849,916 546,307 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
deCODE Genetics Common 24386104 2,876,750 1,555,000 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Dyax Common 26746E103 1,208,021 694,265 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Eclipsys Common 278856109 1,889,127 237,000 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Endocardial
Solutions Common 292962107 4,616,665 1,666,666 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
EP MedSystems Common 26881P103 1,784,500 1,075,000 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Exelixis Common 30161Q104 8,138,520 1,222,000 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Genzyme Common 372917104 4,957,200 136,000 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Gilead Sciences Common 37555B103 15,242,370 363,000 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
IDEXX Laboratories Common 45168D104 8,742,500 250,000 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
IMPAX Laboratories Common 45256B101 3,637,798 810,200 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
IVAX Common 465823102 6,668,900 544,400 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Kosan Biosciences Common 50064W107 3,296,832 739,200 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Lexicon Genetics Common 5288872104 2,274,300 570,000 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Lynx Therapeutics Common 551812308 507,590 283,570 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Martek Biosciences Common 572901106 22,251,989 780,224 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
MedImmune Common 584699102 13,493,130 411,000 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Millennium
Pharmaceuticals Common 599902103 5,482,350 697,500 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Molecular Devices Common 60851C107 3,518,293 290,768 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Orthovita Common 68750U102 5,100,000 1,700,000 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Quintiles
Transnational Common 748767100 1,859,264 152,900 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Rigel Pharmaceuticals Common 766559108 760,350 1,027,500 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Sontra (Restricted) Common 83568W109 1,325,534 1,142,702 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Telik Common 87959M109 8,959,977 666,665 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Transkaryotic
Therapies Common 893735100 2,264,696 382,550 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Tularik Common 899165104 2,047,296 405,405 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Vertex
Pharmaceuticals Common 92532F100 2,109,464 189,700 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
Vicuron
Pharmaceuticals Common 925314106 7,547,871 696,941 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
WebMD Common 94769M105 6,832,650 757,500 X NA X
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
COLUMN TOTALS $204,773,797
-----------------------------------------------------------------------------------------------------------------------------------